🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsDosing & ProtocolsHalf-life implications for missed doses — looking for input

Half-life implications for missed doses — looking for input

MeganSA_TX Thu, Jan 9, 2025 at 1:11 AM 9 replies 1,669 viewsPage 1 of 2
This thread is more than 17 months old. Information may be outdated. Consider searching for more recent discussions.
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Jan 9, 2025 at 1:11 AM#1

Writing this once so I can stop repeating it across threads. It is about a missed or late dose, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

With a one-week half-life a dose three days late does not reset anything — you are dosing onto roughly half the previous concentration rather than a third, and the practical effect is a slightly larger effective step. The usual guidance is to take it if you are within about five days and to skip it and resume the schedule if you are past that, because a dose taken two days before the next one stacks exposure.

The condition it depends on

That works for the weekly agents. On a daily oral a missed dose is nearly irrelevant, which is a genuine and rarely stated advantage of the tablets.

The practical version

Practical rule most prescribers use for weekly dosing: within five days, take it and keep the original day; past five days, skip it and resume. Do not double.

What I am not sure about

The question I want answered is whether a dose three days late resets the ladder or just shifts it. Happy to be told the question itself is wrong.

— MeganSA_TX · corrections welcome and will be edited into this post with credit
50 20PharmD_Rodriguez, julia.endo, JessicaM_2024 and 47 others
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Jan 9, 2025 at 2:14 AM#2
MeganSA_TX said:
With a one-week half-life a dose three days late does not reset anything — you are dosing onto roughly half the previous concentration rather than a…

Agreed, and the adaptation point cuts both ways: tachyphylaxis to gastric emptying is why tolerability improves, and it is also why people who were relying on physical fullness feel the effect fade while the appetite effect is still working.

49 19MariaRD, AussieAnna, BethLabQueen and 46 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Jan 9, 2025 at 3:17 AM#3
MeganSA_TX said:
With a one-week half-life a dose three days late does not reset anything — you are dosing onto roughly half the previous concentration rather than a…

Missed dose question about a missed dose: I'm 2 days late on my injection. Should I take it now or wait until my regular day?

UPDATE: Called my provider — they said take it now and resume my regular schedule next week. Apparently being a few days late isn't a big deal as long as you don't double up.

48 18RetaRick_CA, JenPlateau, SallyK_inj and 45 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Jan 9, 2025 at 4:20 AM#4

Short answer first, then the reasoning. The mechanism is more central than most summaries suggest. Receptor agonism in the arcuate nucleus activates POMC neurons and inhibits AgRP/NPY signalling, and the downstream MC4R pathway is the same one disrupted in monogenic obesity — convergent genetic evidence that the target is the right one. Peripherally there is glucose-dependent insulin secretion, glucagon suppression and delayed gastric emptying, but the gastric component largely adapts over months while the central effect persists, which is why the durable effect is appetite rather than fullness.

Last edited: Jan 9, 2025 at 5:20 AM
47 17DebRD_ATL, KristenIndy, MarkLI_maint and 44 others
Reply Quote Save Share Report
MikeNYC_runner
Member
378
1,678
Jul 2024
New York, NY
Jan 9, 2025 at 10:19 AM#5
anders_CPH said:
Agreed, and the adaptation point cuts both ways: tachyphylaxis to gastric emptying is why tolerability improves, and it is also why people who were…

Same pattern here, and in the same order. I had assumed I was the exception until I read this.

Last edited: Jan 9, 2025 at 12:19 PM
46 16MASHdoc_SA, GenomicsKate, Dr.ObesityMed and 43 others
Reply Quote Save Share Report

Similar Threads

Micro-dosing semaglutide — is sub-therapeutic dosing effective?16 replies
Injection technique: subcutaneous depot formation and absorption8 replies
Semaglutide PK modeling — when to time your injection12 replies
Reconstitution calculator — compounded peptide dosing math7 replies
Half-life implications for missed doses — PK-based guidance5 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register